International Stem Cell CORP
ISCO· OTC
Released Apr 12, 2019, after the close
10-K filed Apr 15, 2019, 105 days after period end · 0001564590-19-011540
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.22M | $1.84M | $1.69M | $1.98M |
| Net Income | -$1.03M | -$1.39M |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $2.16M |
| -$1.53M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.